Ferlatum Рiron formulation replenishes the lack of iron in the body. The main function of iron is to carry oxygen to the tissues. The iron part of hemoglobin, myoglobin, cytochrome iron-containing enzymes, and transfers electrons acts as a catalyst of oxidation reactions, hydroxylation and other metabolic processes.Ferlatum contains iron suktsinilat protein, which is a complex compound in which atoms of ferric iron (Fe3 +) are surrounded by a semi-synthetic protein carrier, preventing damage to the gastric mucosa. The protein carrier is dissolved again in the duodenum, liberating iron in place of its better absorption. From the intestine into the blood equipoise cycle ferric goes through active absorption, which explains the impossibility of overdose and poisoning.


Indications for use:


  • Treatment of latent and symptomatic iron deficiency (iron deficiency anemia);
  • Preventive treatment of iron deficiency during pregnancy, lactation, active growth;After prolonged bleeding, against defective and unbalanced diet.


  • Hypersensitivity to the drug;
  • Iron overload (hemochromatosis);
  • Violation of iron utilization (lead anemia, sideroahrestical anemia);
  • Nezhelezodefitsitnye anemia (hemolytic anemia, megaloblastic anemia caused by lack of vitamin B12);
  • Chronic pancreatitis;
  • Cirrhosis of the liver.Pregnancy and lactation
    Use of the drug Ferlatum can be recommended for the prevention and treatment of iron deficiency that develops during pregnancy and lactation. 

    Dosage and administration:

    Ferlatum taken orally before or after a meal.
    Adults: 1-2 bottle daily amount equivalent to 40-80 mg of Fe3 + or doctor in accordance with the recommendations in 2 hours.
    Children: 1.5 ml / kg / day (in an amount equivalent to 4 mg / kg / day, Fe3 +) in 2 hours or according to a physician’s recommendations.

    Pregnant women:
    For the prevention of iron deficiency equipoise cycle anemia Р1 bottle per day. For the treatment of latent or symptomatic iron deficiency Р1-2 bottles a day in 2 divided doses. After reaching normal levels of hemoglobin and serum iron treatment is continued for at least 8-12 weeks, assigning a maintenance dose.

    Side effects:
    In rare cases, may cause gastro-intestinal disorders (including diarrhea, constipation, nausea and epigastric pain), usually using higher doses Ferlatuma that disappear with dose reduction or withdrawal of the drug.



    So far it has not been described signs of intoxication and excess revenues Ferlatum the drug into the body.However, the first 6-8 hours after the application of excessive doses of iron preparations may cause epigastric pain, nausea, vomiting (sometimes with blood), diarrhea, in some cases accompanied by lethargy, pale skin.Perhaps the development of shock up to coma.Immediate therapeutic measures to the provision of skilled care include gastric lavage.


    Interaction with other drugs:

    There was no interaction Ferlatuma with other drugs.However, iron tetracycline derivatives contribute to disruption of absorption in the gastrointestinal tract and thereby avoid the simultaneous application of them.iron absorption can be increased with concomitant administration of 200 mg of ascorbic acid and reduced by the application of antacids.Chloramphenicol is a delayed response to iron therapy.Noting the absence of pharmacological interaction with concomitant treatment of H2-receptor antagonists.


    Special instructions:

    Continuous application period equipoise cycle should not exceed 6 months, except in cases of chronic blood loss (menorrhagia, haemorrhoids, etc.) And pregnancy.It does not affect the classes of potentially hazardous activities that require high concentration and speed of psychomotor reactions (including driving motor vehicles).


    Product form:

    Oral solution 800 mg 15 ml in plastic vials, sealed with plastic covers to control the first opening. 10 or 20 vials with the instruction in the carton box.